• Sales
  • Results
  • Cashflow
  • Share
  • Investments/​R&D
  • Currency effects
Sales
Results
Cashflow
Share
Investments/​R&D expenditures
Currency effects

Sales +3.1% Currency-adjusted sales growth in 2018

Chart is loading ...
Chart is loading ...
*Adjusted for costs in connection with the Sanitec acquisition and integration (EBITDA 2018 not adjusted)
Chart is loading ...
* Adjusted for costs in connection with the Sanitec acquisition and integration

Operating cashflow margin (EBITDA margin)
  28.2% Around previous year's performance

Free cashflow
(in CHF) 582 million +22.2% versus prior year

Adjusted earnings per share
(in CHF) 17.21 +4.7% versus prior year

Payout ratio

62.7% The payout ratio is in the upper range of the target corridor of 50 to 70%

Investments in property, plant and equipment and intangible assets
(in CHF) 162 million +1.9% versus prior year

R&D expenditures
(in CHF)

78 million Around previous year's performance

Currency effects in EBIT
(in CHF) +16 million

Currency effects in net sales
(in CHF) +83 million